Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8706 |
High Similarity |
NPD6232 |
Discontinued |
0.8671 |
High Similarity |
NPD5844 |
Phase 1 |
0.8663 |
High Similarity |
NPD7473 |
Discontinued |
0.8623 |
High Similarity |
NPD2801 |
Approved |
0.8623 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8563 |
High Similarity |
NPD1934 |
Approved |
0.8412 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8402 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8402 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8371 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8353 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8286 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8286 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8286 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8266 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8256 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8218 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8202 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8198 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8197 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8192 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8146 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8144 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8144 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8144 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8111 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8101 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8084 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8081 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.807 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8059 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8056 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8011 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7956 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7931 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7912 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.791 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7907 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD919 |
Approved |
0.7877 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7869 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7841 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7841 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7784 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7747 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7719 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD37 |
Approved |
0.7701 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7684 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7684 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7684 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7679 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7667 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7667 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7665 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7634 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7634 |
Intermediate Similarity |
NPD8313 |
Approved |
0.763 |
Intermediate Similarity |
NPD920 |
Approved |
0.7629 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7611 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7606 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7602 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7584 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7538 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7538 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7538 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7538 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7538 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7538 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7538 |
Intermediate Similarity |
NPD6778 |
Approved |
0.753 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7529 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7456 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7456 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7456 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7432 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7427 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7425 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7405 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.738 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7377 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7376 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7365 |
Intermediate Similarity |
NPD943 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7341 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7326 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5401 |
Approved |
0.73 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.73 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7286 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7282 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7282 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7277 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7262 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7249 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7249 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7247 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7184 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7159 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7119 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7083 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7076 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7066 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7056 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7052 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7052 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7052 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7047 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7044 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7043 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7035 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7031 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7028 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7028 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.699 |
Remote Similarity |
NPD4287 |
Approved |
0.6978 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.697 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6965 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD5353 |
Approved |
0.6947 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6946 |
Remote Similarity |
NPD1203 |
Approved |
0.6941 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD7985 |
Registered |
0.6934 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6934 |
Remote Similarity |
NPD4665 |
Approved |
0.6932 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6919 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6919 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD2344 |
Approved |
0.6914 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6902 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6893 |
Remote Similarity |
NPD7584 |
Approved |
0.6893 |
Remote Similarity |
NPD7003 |
Approved |
0.6889 |
Remote Similarity |
NPD6273 |
Approved |
0.6889 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6867
|
Remote Similarity |
NPD9269 |
Phase 2 |